Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinical Trial, Phase 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07181837
What this trial is testing

The Safety and Efficacy of MVX-220 in Angelman Syndrome

Who this might be right for
Angelman Syndrome
MavriX Bio, LLC 12
Early research (Phase 1)Looking for participantsNCT06047977
What this trial is testing

Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors

Who this might be right for
Lymphocytes
H. Lee Moffitt Cancer Center and Research Institute 30
Large-scale testing (Phase 3)Ended earlyNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 480
Early research (Phase 1)WithdrawnNCT03773328
What this trial is testing

A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS)

Who this might be right for
Guillain-Barré Syndrome
Cellenkos, Inc.
Testing effectiveness (Phase 2)Study completedNCT04453241
What this trial is testing

Immunogenicity and Safety Study of NBP615 in Healthy Female

Who this might be right for
Cervical Cancer
SK Bioscience Co., Ltd. 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03625037
What this trial is testing

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

Who this might be right for
DLBCLHigh-grade B-cell Lymphoma (HGBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)+6 more
Genmab 666
Early research (Phase 1)Ended earlyNCT02136342
What this trial is testing

Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Chinese Academy of Medical Sciences
Early research (Phase 1)Study completedNCT02644694
What this trial is testing

PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy

Who this might be right for
Vitrectomy
Eyegate Pharmaceuticals, Inc. 10
Large-scale testing (Phase 3)Study completedNCT00864383
What this trial is testing

Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 1,931
Early research (Phase 1)Study completedNCT06665425
What this trial is testing

PK,PD and DDI of Epaminurad and C2406 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
JW Pharmaceutical 18
Testing effectiveness (Phase 2)Study completedNCT06810050
What this trial is testing

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
CAGE Bio Inc. 180
Testing effectiveness (Phase 2)Ended earlyNCT01455389
What this trial is testing

TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer

Who this might be right for
Lung Cancer
Genprex, Inc. 25
Early research (Phase 1)Study completedNCT02376582
What this trial is testing

Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS

Who this might be right for
HIV/AIDS
EuroVacc Foundation 72
Early research (Phase 1)Study completedNCT01050127
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults

Who this might be right for
Healthy
Abbott 36
Testing effectiveness (Phase 2)UnknownNCT01957826
What this trial is testing

Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy

Who this might be right for
Primary Idiopathic Dilated Cardiomyopathy
Hospital General Universitario Gregorio Marañon 70
Early research (Phase 1)Not Yet RecruitingNCT07826676
What this trial is testing

Use of Bone Marrow Stem Cells (MesenCell) for the Treatment of Patients With Chronic Graft-versus-host Disease

Who this might be right for
Graft vs Host DiseaseMesenchymal Stem Cell Transplantation
Pontifícia Universidade Católica do Paraná 20
Early research (Phase 1)Ended earlyNCT03558750
What this trial is testing

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Who this might be right for
Recurrent Central Nervous System LymphomaRecurrent Diffuse Large B-Cell LymphomaRefractory Central Nervous System Lymphoma+1 more
Vanderbilt-Ingram Cancer Center 6
Early research (Phase 1)Not Yet RecruitingNCT07800897
What this trial is testing

Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants

Who this might be right for
Healthy Female Adults
Bristol-Myers Squibb 80
Early research (Phase 1)Study completedNCT00929396
What this trial is testing

A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Derivative (PPD) Positive Volunteers

Who this might be right for
Tuberculosis
Statens Serum Institut 20
Early research (Phase 1)WithdrawnNCT01251250
What this trial is testing

Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Refractory Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more
Roswell Park Cancer Institute
Next Page